<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00262</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (ii) Strain specific positive controls shall be included in  <!-- PJG 0012 frnewline --> the assay. Examples of strain specific positive controls are as  <!-- PJG 0012 frnewline --> follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 --> (A) Strain TA1535, TA100: sodium azide;  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (B) TA98: 2-nitrofluorene (without activation), 2- <!-- PJG 0012 frnewline --> anthramine (with activation);  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (C) TA1537: 9-aminoacridine; and  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (D) TA98/1,8&hyph;DNP <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=5 f=2 --> 6 <!-- PJG /ITAG -->  <!-- PJG ITAG l=15 g=1 f=1 --> : benzo(a)pyrene (with activation).  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The papers by Claxton  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> et al. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , 1991 and 1992 in paragraph (g) in  <!-- PJG 0012 frnewline --> this section will provide helpful information for the selection  <!-- PJG 0012 frnewline --> of positive controls.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Positive controls to ensure the efficacy of the  <!-- PJG 0012 frnewline --> activation system.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The positive control reference substances for  <!-- PJG 0012 frnewline --> tests including a metabolic activation system shall be selected  <!-- PJG 0012 frnewline --> on the basis of the type of activation system used in the test.  <!-- PJG 0012 frnewline --> 2-Aminoanthracene is an example of a positive control compound in  <!-- PJG 0012 frnewline --> plate-incorporation tests using postmitochondrial fractions from  <!-- PJG 0012 frnewline --> the livers of rodents treated with enzyme-inducing agents such as  <!-- PJG 0012 frnewline --> Aroclor-1254. Congo red is an example of a positive control  <!-- PJG 0012 frnewline --> compound in the azo-reduction method. Other positive control  <!-- PJG 0012 frnewline --> reference substances may be used.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (iv)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Class-specific positive controls.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The azo-reduction  <!-- PJG 0012 frnewline --> method shall include positive controls from the same class of  <!-- PJG 0012 frnewline --> compounds as the test agent wherever possible.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (6)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Sampling the test atmosphere. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(i) Extracts of test emissions are collected on Teflon <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -coated glass fiber filters using an exhaust dilution setup. The particulates are extracted with dichloromethane (DCM) using  <!-- PJG 0012 frnewline --> Soxhlet extraction techniques. Extracts in DCM can be stored at  <!-- PJG 0012 frnewline --> dry ice temperatures until use.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (ii) Gaseous hydrocarbons passing through the filter are  <!-- PJG 0012 frnewline --> trapped by a porous, polymer resin, like XAD&hyph;2/styrene- <!-- PJG 0012 frnewline --> divinylbenzene, or an equivalent product. Methylene chloride is  <!-- PJG 0012 frnewline --> used to extract the resin and the sample is evaporated to dryness  <!-- PJG 0012 frnewline --> before storage or use.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iii) Samples taken from this material are then used to  <!-- PJG 0012 frnewline --> expose the cells in this assay. Final concentration of extracts  <!-- PJG 0012 frnewline --> in solvent/vehicle, or after solvent exchange, shall not  <!-- PJG 0012 frnewline --> interfere with cell viability or growth rate. The paper by Stump  <!-- PJG 0012 frnewline --> (1982) in paragraph (g) of this section is useful for preparing  <!-- PJG 0012 frnewline --> extracts of particulate and semi-volatile organic compounds from  <!-- PJG 0012 frnewline --> diesel and gasoline exhaust stream.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (iv) Exposure concentrations. (A) The test should initially be performed over a broad  <!-- PJG 0012 frnewline --> range of concentrations. Among the criteria to be taken into  <!-- PJG 0012 frnewline --> consideration for determining the upper limits of test substance  <!-- PJG 0012 frnewline --> concentration are cytotoxicity and solubility. Cytotoxicity of  <!-- PJG 0012 frnewline --> the test chemical may be altered in the presence of metabolic  <!-- PJG 0012 frnewline --> activation systems. Toxicity may be evidenced by a reduction in  <!-- PJG 0012 frnewline --> the number of spontaneous revertants, a clearing of the  <!-- PJG 0012 frnewline --> background lawn or by the degree of survival of treated cultures.  <!-- PJG 0012 frnewline --> Relatively insoluble samples shall be tested up to the limits of  <!-- PJG 0012 frnewline --> solubility. The upper test chemical concentration shall be  <!-- PJG 0012 frnewline --> determined on a case by case basis.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (B) Generally, a maximum of 5 mg/plate for pure substances  <!-- PJG 0012 frnewline --> is considered acceptable. At least 5 different concentrations of  <!-- PJG 0012 frnewline --> test substance shall be used with adequate intervals between test  <!-- PJG 0012 frnewline --> points.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (C) When appropriate, a single positive response shall be  <!-- PJG 0012 frnewline --> confirmed by testing over a narrow range of concentrations.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (e)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Test performance.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All data developed within this study  <!-- PJG 0012 frnewline --> shall be in accordance with good laboratory practice provisions  <!-- PJG 0012 frnewline --> under &sect;79.60.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (1) Direct plate incorporation method. When testing with  <!-- PJG 0012 frnewline --> metabolic activation, test solution, bacteria, and 0.5 ml of  <!-- PJG 0012 frnewline --> activation mixture containing an adequate amount of  <!-- PJG 0012 frnewline --> postmitochondrial fraction shall be added to the liquid overlay  <!-- PJG 0012 frnewline --> agar and mixed. This mixture is poured over the surface of a  <!-- PJG 0012 frnewline --> selective agar plate. Overlay agar shall be allowed to solidify  <!-- PJG 0012 frnewline --> before incubation. At the end of the incubation period,  <!-- PJG 0012 frnewline --> revertant colonies per plate shall be counted. When testing  <!-- PJG 0012 frnewline --> without metabolic activation, the test sample and 0.1 ml of a  <!-- PJG 0012 frnewline --> fresh bacterial culture shall be added to 2.0 ml of overlay agar.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (2) Azo-reduction method. When testing with metabolic  <!-- PJG 0012 frnewline --> activation, 0.5 ml of activation mixture containing 150 &mu;l of  <!-- PJG 0012 frnewline --> postmitochondrial fraction and 0.1 ml of bacterial culture shall  <!-- PJG 0012 frnewline --> be added to a test tube kept on ice. 0.1 ml of test solution  <!-- PJG 0012 frnewline --> shall be added, and the tubes shall be incubated with shaking at  <!-- PJG 0012 frnewline --> 30  <!-- PJG 0040 degreeslatlong --> &cir;C for 30 minutes. At the end of the incubation period, 2.0  <!-- PJG 0012 frnewline --> ml of agar shall be added to each tube, the contents mixed and  <!-- PJG 0012 frnewline --> poured over the surface of a selective agar plate. Overlay agar  <!-- PJG 0012 frnewline --> shall be allowed to solidify before incubation. At the end of the  <!-- PJG 0012 frnewline --> incubation period, revertant colonies per plate shall be counted.  <!-- PJG 0012 frnewline --> For tests without metabolic activation, 0.5 ml of buffer shall be  <!-- PJG 0012 frnewline --> used in place of the 0.5 ml of activation mixture. All other  <!-- PJG 0012 frnewline --> procedures shall be the same as those used for the test with  <!-- PJG 0012 frnewline --> metabolic activation.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> (3) Other methods/modifications may also be appropriate.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  (4) Media. An appropriate selective medium with an adequate  <!-- PJG 0012 frnewline --> overlay agar shall be used.  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            